Neurology

Phase II trial of novel carbidopa/levodopa formulation

 

A new extended-release formulation of carbidopa/levodopa (CD/LD) appears to be as effective as standard CD/LD in stable patients with Parkinson’s disease, according to the results of a small phase II study (Hinson et al. Clin Neuropharmacol 2009; 32: 189-192).

Read More

TOPICS:

Pilot study of modafinil for fatigue in PD

 

Modafinil may reduce physical fatiguability but does not appear to alleviate fatigue symptoms in patients with Parkinson’s disease, according to the results of a placebo-controlled pilot study (Lou et al. Clin Neuropharmacol 2009; epublished June 10, 2009).

Read More

TOPICS:

EBV: an association with MS?

 

A history of infectious mononucleosis caused by the Epstein-Barr virus (EBV) appears to be associated with an increased susceptibility to MS, according to an analysis by the Canadian Collaborative Study Group (Ramagopalan et al. Neuroepidemiology 2009; 32: 257-262).

Read More

TOPICS: